Clinical Trial Update: A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR) [Phase 3]

View source ↗

Summary

A Phase 3 COPD trial (FAIR) sponsored by Chiesi Farmaceutici has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: TERMINATED